Replies to post #159447 on Biotech Values

[mcbio]

Just for me seemed like an ERA has some safety risk and not clear it'll work well enough considering there are some other (granted suboptimal) treatment options.

Just keep in mind that RE-021 is both an ERA and angiotensin receptor blocker (ARB), for better or worse.